EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Modulation of Alzheimer’s disease pathogenesis by the FGF-FGFR axis: therapeutic implications and translational perspectives

Anas Saifi, Mahendra Bishnoi, Rahul Deshmukh

Molecular Biology Reports · 2026-12 · 53 (1)

DOI: 10.1007/s11033-026-13012-1 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Biology Reports, online erschienen am 04.11.2026. Verfasst von Anas Saifi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Health Sciences, Central University of Punjab, Bathinda, Punjab, India. Hauptthemen laut MEDLINE: Alzheimer Disease, Fibroblast Growth Factors, Receptors, Fibroblast Growth Factor. Die Arbeit nennt 92 Literaturangaben. Gefördert von: Indian Council of Medical Research, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) is the neurodegenerative disease characterised by deposition of senile amyloid-β (Aβ) plaques. It is a progressive disease which results in cognitive impairment and memory loss. There is no promising cure available so far for this disease due to its complex pathogenesis. The complex pathogenesis of AD involves multiple interconnected mechanisms, including Aβ plaque accumulation, tau protein hyperphosphorylation leading to neurofibrillary tangle formation, and damage to cholinergic synapses that impair neurotransmission. Additionally, neuroinflammation, oxidative stress, metal ion dyshomeostasis, glutamatergic excitotoxicity, disrupted autophagy processes, and alterations in the gut-brain axis contribute to disease progression. Emerging evidence highlights the potential role of Fibroblast growth factors (FGFs) and their receptors (FGFRs) in neurodegenerative diseases. FGF-FGFR system is crucial for cellular proliferation, differentiation, migration, and survival. The FGF-FGFR system system plays significant roles in various biological processes such as wound healing, angiogenesis, tissue regeneration, and embryonic development. Numerous FGFs and FGFRs are expressed in the central nervous system, where they are believed to exert neuroprotective and neurotrophic effects. Emerging evidence suggests that modulating this pathway could offer therapeutic benefits in neurodegenerative diseases, including AD, by intervening in multiple pathogenic cascades. This review emphasizes the significance of the FGF-FGFR system in AD, exploring their roles in disease pathogenesis, the development of novel drug delivery routes, and advanced delivery systems for FGF-based therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseFibroblast Growth FactorsReceptors, Fibroblast Growth FactorHumansAnimalsSignal TransductionAmyloid beta-Peptidestau Proteins

Stichwörter der Autor:innen

Alzheimer’s diseaseAβFibroblast growth factorTau Hyperphosphorylation, Neuroinflammation

Substanzen

Fibroblast Growth FactorsReceptors, Fibroblast Growth FactorAmyloid beta-Peptidestau Proteins

Autor:innen und Institutionen

  • Department of Pharmacology, School of Health Sciences, Central University of Punjab, Bathinda, Punjab, India.
  • TR(i)P for Health Laboratory, Food and Nutrition Biotechnology Division, BRIC-National Agri-Food and Biomanufacturing Institute (BRIC-NABI), S.A.S. Nagar, Mohali, Punjab, India.
  • Department of Pharmacology, School of Health Sciences, Central University of Punjab, Bathinda, Punjab, India. drrahuld09@gmail.com.

Förderung

  • Indian Council of Medical Research, India

Zitieren

APA

Saifi, A., Bishnoi, M., & Deshmukh, R. (2026). Modulation of Alzheimer’s disease pathogenesis by the FGF-FGFR axis: therapeutic implications and translational perspectives. Molecular Biology Reports, 53(1). https://doi.org/10.1007/s11033-026-13012-1

Vancouver

Saifi A, Bishnoi M, Deshmukh R. Modulation of Alzheimer’s disease pathogenesis by the FGF-FGFR axis: therapeutic implications and translational perspectives. Molecular Biology Reports. 2026;53(1). doi:10.1007/s11033-026-13012-1

BibTeX
@article{Saifi2026,
  author = {Saifi, Anas and Bishnoi, Mahendra and Deshmukh, Rahul},
  title = {Modulation of Alzheimer’s disease pathogenesis by the FGF-FGFR axis: therapeutic implications and translational perspectives},
  journal = {Molecular Biology Reports},
  year = {2026},
  volume = {53},
  number = {1},
  doi = {10.1007/s11033-026-13012-1}
}
Kostenlos starten →